Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2011

Open Access 01-12-2011 | Study protocol

Which dressing do donor site wounds need?: study protocol for a randomized controlled trial

Authors: Anne M Eskes, Fleur E Brölmann, Louise AA Gerbens, Dirk T Ubbink, Hester Vermeulen, The REMBRANDT study group (REMBRANDT)

Published in: Trials | Issue 1/2011

Login to get access

Abstract

Background

Donor site wounds after split-skin grafting are rather 'standard' wounds. At present, lots of dressings and topical agents for donor site wounds are commercially available. This causes large variation in the local care of these wounds, while the optimum 'standard' dressing for local wound care is unclear. This protocol describes a trial in which we investigate the effectiveness of various treatment options for these donor site wounds.

Methods

A 14-center, six-armed randomized clinical trial is being carried out in the Netherlands. An a-priori power analysis and an anticipated dropout rate of 15% indicates that 50 patients per group are necessary, totaling 300 patients, to be able to detect a 25% quicker mean time to complete wound healing. Randomization has been computerized to ensure allocation concealment. Adult patients who need a split-skin grafting operation for any reason, leaving a donor site wound of at least 10 cm2 are included and receive one of the following dressings: hydrocolloid, alginate, film, hydrofiber, silicone dressing, or paraffin gauze. No combinations of products from other intervention groups in this trial are allowed. Optimum application and changes of these dressings are pursued according to the protocol as supplied by the dressing manufacturers. Primary outcomes are days to complete wound healing and pain (using a Visual Analogue Scale). Secondary outcomes are adverse effects, scarring, patient satisfaction, and costs. Outcome assessors unaware of the treatment allocation will assess whether or not an outcome has occurred. Results will be analyzed according to the intention to treat principle. The first patient was randomized October 1, 2009.

Discussion

This study will provide comprehensive data on the effectiveness of different treatment options for donor site wounds. The dressing(s) that will prevail in effectiveness, satisfaction and costs will be promoted among clinicians dealing with such patients. Thus, we aim to contribute a well-designed trial, relevant to all clinicians involved in the care for donor site wounds, which will help enhance uniformity and quality of care for these patients.

Trial registration

http://​www.​trialregister.​nl, NTR1849. Date registered: June 9, 2009
Appendix
Available only for authorised users
Literature
1.
Rakel BA, Bermel MA, Abbott LI, Baumler SK, Burger MR, Dawson CJ, Heinle JA, Ocheltree IM: Split-thickness skin graft donor site care: a quantitative synthesis of the research. Appl Nurs Res. 1998, 11 (4): 174-182. 10.1016/S0897-1897(98)80296-6.CrossRefPubMed
2.
Wiechula R: The use of moist wound-healing dressings in the management of split-thickness skin graft donor sites: a systematic review. Int J Nurs Pract. 2003, 9 (2): S9-17. 10.1046/j.1322-7114.2003.00417.x.CrossRefPubMed
3.
Ratner D: Skin grafting. Semin Cutan Med Surg. 2003, 22 (4): 295-305. 10.1016/S1085-5629(03)00079-8.CrossRefPubMed
4.
Persson K, Salemark L: How to dress donor sites of split thickness skin grafts: a prospective, randomised study of four dressings. Scand J Plast Reconstr Surg Hand Surg. 2000, 34 (1): 55-59. 10.1080/02844310050160178.CrossRefPubMed
5.
Feldman DL: Which dressing for split-thickness skin graft donor sites?. Ann Plast Surg. 1991, 27 (3): 288-291. 10.1097/00000637-199109000-00017.CrossRefPubMed
6.
Voineskos SH, Ayeni OA, McKnight L, Thoma A: Systematic review of skin graft donor-site dressings. Plast Reconstr Surg. 2009, 124 (1): 298-306. 10.1097/PRS.0b013e3181a8072f.CrossRefPubMed
7.
Schreuder SM, Qureshi MA, Vermeulen H, Ubbink DT: Dressings and topical agents for treating donor sites of split-skin grafts: a systematic review [abstract]. EWMA Journal. 2009, 9 (3): 22-
8.
Eskes AM, Gerbens LAA, Ubbink DT, Vermeulen H: [Current treatment policies of donor site wounds after split-skin grafting: a national survey]. Ned Tijdschr Heelkd. 2011, 20 (2): 66-69. [Dutch]
9.
Geary PM, Tiernan E: Management of split skin graft donor sites--results of a national survey. J Plast Reconstr Aesthet Surg. 2009, 62 (12): 1677-1683. 10.1016/j.bjps.2008.07.036.CrossRefPubMed
10.
Lyall PW, Sinclair SW: Australasian survey of split skin graft donor site dressings. Aust N Z J Surg. 2000, 70 (2): 114-116. 10.1046/j.1440-1622.2000.01767.x.CrossRefPubMed
11.
12.
13.
Barnea Y, Amir A, Leshem D, Zaretski A, Weiss J, Shafir R, Gur E: Clinical comparative study of aquacel and paraffin gauze dressing for split-skin donor site treatment. Ann Plast Surg. 2004, 53 (2): 132-136. 10.1097/01.sap.0000112349.42549.b3.CrossRefPubMed
14.
Lohsiriwat V, Chuangsuwanich A: Comparison of the ionic silver-containing hydrofiber and paraffin gauze dressing on split-thickness skin graft donor sites. Ann Plast Surg. 2009, 62 (4): 421-422. 10.1097/SAP.0b013e31818a65e9.CrossRefPubMed
15.
Ubbink DT, Vermeulen H, Goossens A, Kelner RB, Schreuder SM, Lubbers MJ: Occlusive vs gauze dressings for local wound care in surgical patients: a randomized clinical trial. Arch Surg. 2008, 143 (10): 950-955. 10.1001/archsurg.143.10.950.CrossRefPubMed
16.
Malpass KG, Snelling CF, Tron V: Comparison of donor-site healing under Xeroform and Jelonet dressings: unexpected findings. Plast Reconstr Surg. 2003, 112 (2): 430-439. 10.1097/01.PRS.0000070408.33700.C7.CrossRefPubMed
17.
O'Donoghue JM, O'Sullivan ST, O'Shaughnessy M, O'Connor TP: Effects of a silicone-coated polyamide net dressing and calcium alginate on the healing of split skin graft donor sites: a prospective randomised trial. Acta Chir Plast. 2000, 42 (1): 3-6.PubMed
18.
Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG: CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010, 340: c869-10.1136/bmj.c869.CrossRefPubMedPubMedCentral
19.
Vermeulen H, Westerbos SJ, Ubbink DT: Benefit and harm of iodine in wound care: a systematic review. J Hosp Infect. 2010, 76 (3): 191-199. 10.1016/j.jhin.2010.04.026.CrossRefPubMed
20.
Vermeulen H, Ubbink DT, de Zwart F, Goossens A, de Vos R: Preferences of patients, doctors, and nurses regarding wound dressing characteristics: a conjoint analysis. Wound Repair Regen. 2007, 15 (3): 302-307. 10.1111/j.1524-475X.2007.00230.x.CrossRefPubMed
21.
van de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP: Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plast Reconstr Surg. 2005, 116 (2): 514-522. 10.1097/01.prs.0000172982.43599.d6.CrossRefPubMed
22.
Schulz KF, Grimes DA: Generation of allocation sequences in randomised trials: chance, not choice. Lancet. 2002, 359 (9205): 515-519.CrossRefPubMed
23.
Farrokhyar F, Karanicolas PJ, Thoma A, Simunovic M, Bhandari M, Devereaux PJ, Anvari M, Adili A, Guyatt G: Randomized controlled trials of surgical interventions. Ann Surg. 2010, 251 (3): 409-416. 10.1097/SLA.0b013e3181cf863d.CrossRefPubMed
24.
Ubbink D, Vermeulen H: The challenge of using randomized trials in wound healing (Br J Surg 2010; 97: 303-304). Br J Surg. 2010, 97 (7): 1147-1148.CrossRefPubMed
25.
Birkmeyer JD, Sun Y, Wong SL, Stukel TA: Hospital volume and late survival after cancer surgery. Ann Surg. 2007, 245 (5): 777-783. 10.1097/01.sla.0000252402.33814.dd.CrossRefPubMedPubMedCentral
26.
Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, Obertop H: Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000, 232 (6): 786-795. 10.1097/00000658-200012000-00007.CrossRefPubMedPubMedCentral
27.
Holt PJ, Poloniecki JD, Gerrard D, Loftus IM, Thompson MM: Meta-analysis and systematic review of the relationship between volume and outcome in abdominal aortic aneurysm surgery. Br J Surg. 2007, 94 (4): 395-403. 10.1002/bjs.5710.CrossRefPubMed
28.
Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF: The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery. 2002, 131 (1): 6-15. 10.1067/msy.2002.120238.CrossRefPubMed
29.
Shervin N, Rubash HE, Katz JN: Orthopaedic procedure volume and patient outcomes: a systematic literature review. Clin Orthop Relat Res. 2007, 457: 35-41.CrossRefPubMed
30.
Gottrup F, Apelqvist J: The challenge of using randomized trials in wound healing. Br J Surg. 2010, 97 (3): 303-304. 10.1002/bjs.7030.CrossRefPubMed
31.
Eskes AM, Gerbens LA, van der Horst CM, Vermeulen H, Ubbink DT: Is the red-yellow-black scheme suitable to classify donor site wounds? An inter-observer analysis. Burns. 2011, 37 (5): 823-827. 10.1016/j.burns.2010.12.019.CrossRefPubMed
32.
Carlsson AM: Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983, 16 (1): 87-101. 10.1016/0304-3959(83)90088-X.CrossRefPubMed
33.
Williamson A, Hoggart B: Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005, 14 (7): 798-804. 10.1111/j.1365-2702.2005.01121.x.CrossRefPubMed
Metadata
Title
Which dressing do donor site wounds need?: study protocol for a randomized controlled trial
Authors
Anne M Eskes
Fleur E Brölmann
Louise AA Gerbens
Dirk T Ubbink
Hester Vermeulen
The REMBRANDT study group (REMBRANDT)
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Trials / Issue 1/2011
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-12-229

Other articles of this Issue 1/2011

Trials 1/2011 Go to the issue

Research

Promoting smoking cessation in Pakistani and Bangladeshi men in the UK: pilot cluster randomised controlled trial of trained community outreach workers

Methodology

Pre-referral rectal artesunate in severe malaria: flawed trial

Study protocol

Homeopathy for Depression - DEP-HOM: study protocol for a randomized, partially double-blind, placebo controlled, four armed study

Research

Analysis and design of randomised clinical trials involving competing risks endpoints

Study protocol

Alzheimer's disease - input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial

Research

A meta-review of evidence on heart failure disease management programs: the challenges of describing and synthesizing evidence on complex interventions